- Medicines and Healthcare products Regulatory Agency
- Part of:
- Import a human medicine: guidance and forms, Patient safety, and Marketing authorisations, variations and licensing guidance
- 6 May 2014
Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products known as 'specials'.
PDF, 356KB, 21 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This Medicines and Healthcare products Regulatory Agency (MHRA) guidance is for those who want to manufacture, import, distribute or supply unlicensed medicines for human use (also known as ‘specials’).
‘Specials’ are products which have been specially manufactured or imported for the treatment of an individual patient after being ordered by a:
- nurse independent prescriber
- pharmacist independent prescriber
- supplementary prescriber
Published: 6 May 2014